Suppr超能文献

白细胞介素-18:癌症与自身免疫性疾病的调节因子。

Interleukin-18: a regulator of cancer and autoimmune diseases.

作者信息

Esmailbeig Maryam, Ghaderi Abbas

机构信息

Shiraz Institute for Cancer Research, School of Medicine, Shiraz University of Medical Sciences.

Shiraz Institute for Cancer Research, School of Medicine, Shiraz University of Medical Sciences, Department of Immunology, School of Medicine Shiraz University of Medical Science, Shiraz Iran.

出版信息

Eur Cytokine Netw. 2017 Nov 1;28(4):127-140. doi: 10.1684/ecn.2018.0401.

Abstract

Interleukin (IL)-18, structurally similar to IL-1β, is a member of IL-1 superfamily of cytokines. This cytokine, which is expressed by many human lymphoid and nonlymphoid cells, has an important role in inflammatory processes. The main function of IL-18 is mediated through induction of interferon-γ (IFN-γ) secretion from T helper (Th1) cells. This cytokine synergistically with IL-12 contributes to Th1 differentiation and, therefore, is important in host defense mechanisms against intracellular bacteria, viruses, and fungi. Recent evidences showing the involvement of IL-18 in Th2 differentiation and ultimately IgE production from B cells have shed a new insight on the dual effects of IL-18 on Th1 and Th2 inflammatory responses. IL-18 in combination with IL-12 can activate cytotoxic T cells (CTLs), as well as natural killer (NK) cells, to produce IFN-γ and, therefore, may contribute to tumor immunity. The biological activity of IL-18 is not limited to these cells, but it also plays a role in development of Th17 cell responses. IL-18 synergistically with IL-23 can induce IL-17 secretion from Th17 cells. The diverse biological activity of IL-18 on T-cell subsets and other immune cells has made this cytokine a good target for investigating its role in various inflammatory-based diseases. Lately, the discovery of IL-18 binding protein (IL-18BP), a physiological inhibitor of IL-18 and a hallmark of IL-18 biology, made this cytokine an attractive target for studying its pros and cons in the treatment of various diseases. In recent years, the biology, genetics, and pathological role of IL-18 have been studied in a number of diseases. In this article, we aimed to present an updated review on these aspects regarding the contribution of IL-18 to important diseases such as cancer, autoimmunity, and inflammatory-mediated conditions including allergic diseases, metabolic syndrome, and atherosclerosis. Emerging data indicating prognostic, diagnostic, and therapeutic features of IL-18 and its related molecules will also be discussed.

摘要

白细胞介素(IL)-18在结构上与IL-1β相似,是细胞因子IL-1超家族的成员。这种由许多人类淋巴细胞和非淋巴细胞表达的细胞因子在炎症过程中起重要作用。IL-18的主要功能是通过诱导辅助性T(Th1)细胞分泌干扰素-γ(IFN-γ)来介导的。这种细胞因子与IL-12协同作用有助于Th1分化,因此在宿主抵御细胞内细菌、病毒和真菌的防御机制中很重要。最近的证据表明IL-18参与Th2分化并最终促进B细胞产生IgE,这为IL-18对Th1和Th2炎症反应的双重作用提供了新的见解。IL-18与IL-12联合可激活细胞毒性T细胞(CTL)以及自然杀伤(NK)细胞以产生IFN-γ,因此可能有助于肿瘤免疫。IL-18的生物学活性不仅限于这些细胞,它在Th17细胞反应的发展中也起作用。IL-18与IL-23协同作用可诱导Th17细胞分泌IL-17。IL-18对T细胞亚群和其他免疫细胞具有多种生物学活性,这使得该细胞因子成为研究其在各种炎症性疾病中作用的良好靶点。最近,白细胞介素-18结合蛋白(IL-18BP)的发现,它是IL-18的生理抑制剂也是IL-18生物学的一个标志,使这种细胞因子成为研究其在各种疾病治疗中的利弊的有吸引力的靶点。近年来,IL-18的生物学、遗传学和病理作用已在多种疾病中进行了研究。在本文中,我们旨在就IL-18对癌症、自身免疫以及包括过敏性疾病、代谢综合征和动脉粥样硬化在内的炎症介导疾病等重要疾病的贡献,对这些方面进行最新综述。还将讨论表明IL-18及其相关分子的预后、诊断和治疗特征的新出现的数据。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验